Louise Holliday Email

Head IP . Autolus

Current Roles

Employees:
470
Revenue:
$2.5M
About
Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered T-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. We are building a leading biotechnology company focussed on the development and commercialisation of engineered T-cell therapies for haematological and solid tumours. Autolus has the ambition to be a leader of a revolution in medicine in which life-threatening diseases are treated by a patient's own cells.
Autolus Address
Autolus Limited
London, null
UK
Autolus Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.